Guardant Health Inc [GH] stock is trading at $64.22, down -1.59%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The GH shares have gain 2.20% over the last week, with a monthly amount glided 13.07%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Guardant Health Inc [NASDAQ: GH] stock has seen the most recent analyst activity on September 25, 2025, when Wolfe Research upgraded its rating to a Outperform but kept the price target unchanged to $75 for it. On April 10, 2025, Mizuho initiated with a Outperform rating and assigned a price target of $55 on the stock. Barclays started tracking the stock assigning a Overweight rating and suggested a price target of $60 on January 23, 2025. Guggenheim upgraded its rating to a Buy but $36 remained the price target by the analyst firm on June 28, 2024.
Guardant Health Inc [GH] stock has fluctuated between $20.14 and $68.00 over the past year. Currently, Wall Street analysts expect the stock to reach $73.33 within the next 12 months. Guardant Health Inc [NASDAQ: GH] shares were valued at $64.22 at the most recent close of the market. An investor can expect a potential return of 14.19% based on the average GH price forecast.
Analyzing the GH fundamentals
Guardant Health Inc [NASDAQ:GH] reported sales of 828.85M for the trailing twelve months, which represents a growth of 30.95%. Gross Profit Margin for this corporation currently stands at 0.63% with Operating Profit Margin at -0.56%, Pretax Profit Margin comes in at -0.5%, and Net Profit Margin reading is -0.5%. To continue investigating profitability, this company’s Return on Assets is posted at -0.31, Equity is 2.19 and Total Capital is -0.42. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-4.37.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Guardant Health Inc’s Current Ratio is 3.71. Further, the Quick Ratio stands at 3.35, while the Cash Ratio is 2.64. Considering the valuation of this stock, the price to sales ratio is 9.66.
Transactions by insiders
Recent insider trading involved Tariq Musa, Director, that happened on Sep 17 ’25 when 116.0 shares were sold. Director, POTTER MYRTLE S completed a deal on Sep 17 ’25 to sell 26.0 shares. Meanwhile, Director POTTER MYRTLE S bought 26.0 shares on Sep 17 ’25.
